Aldeyra Therapeutics - Eyewire+

EyewireTV | 05.11.2022

Now Playing

Eyewire TV May 11, 2022 thumbnail

Introduction

story 1 thumbnail

Executive Updates

story 2 thumbnail

J&J Vision

story 3 thumbnail

Zeiss

story 4 thumbnail

Sight Sciences

story 5 thumbnail

Ocuphire Pharma

story 6 thumbnail

Visus Therapeutics

story 7 thumbnail

Aldeyra Therapeutics

story 8 thumbnail

ViaLase

story 9 thumbnail

Allotex

story 10 thumbnail

BioTissue

Previous EyewireTV Episodes

04.22.2026

Eyewire TV Apil 22, 2026 thumbnail

Introduction

story 1 thumbnail

Glaukos Launches Epioxa for Keratoconus; Secures J-Code

story 2 thumbnail

BVI Receives CE Mark for Virtuoso Phaco-Vitrectomy Surgical System

story 3 thumbnail

ASCRS Executive Director Recaps Annual Sightline Meeting

04.15.2026

Eyewire TV April 15, 2026 thumbnail

Introduction

story 1 thumbnail

J&J Tecnis PureSee EDOF IOL

story 2 thumbnail

Alcon Clareon TruPlus IOL

Oculus Pentacam Cornea OCT thumbnail

Oculus Pentacam Cornea OCT

04.08.2026

Eyewire TV April 8, 2026 thumbnail

Introduction

story 1 thumbnail

Massive Recall Issued for Several OTC Store-Brand Eye Drops

story 2 thumbnail

Dosing Intervals for Eylea HD Extended Up to Every 20 Weeks

story 3 thumbnail

B+L's Preloaded enVista Envy Full Range of Vision IOL Launched in Europe

04.01.2026

Eyewire TV April 1, 2026 thumbnail

Introduction

story 1 thumbnail

Biogen Enters Agreement to Acquire Apellis for $5.6 Billion

story 2 thumbnail

TenPoint Launches Presbyopia Drop Yuvezzi in US

story 3 thumbnail

Kodiak Sciences Releases Phase 3 Data on DR Drug Candidate Zenkuda